People with heart failure, sarcopenia and chagas disease: A systematic review and meta-analysis

Melissa Orlandin Premaor, Suellen de Azevedo Mendes, Gustavo Henrique Silva Ambrósio Vieira, Camila Diniz Braga, Aron Fonseca Santos, Diego Silva Assaf Ferreira, Bruno Cesar Fernandes Araujo, Maria do Carmo Pereira Nunes and Luis Felipe Jose Ravic de Miranda

PLOS Neglected Tropical Diseases, 2025, vol. 19, issue 11, 1-14

Abstract: Background: This systematic review aims to estimate the prevalence of sarcopenia in people with heart failure (HF) and assess whether there is a difference in sarcopenia prevalence based on the underlying cause of HF, specifically comparing HF due to Chagas (HF-C) disease with HF from other causes (HF-NC). Methods: A systematic review of randomized controlled trials, cohort studies, cross-sectional studies, and case-control studies was carried out. Individuals with HF over 18 years who had their frequency of sarcopenia evaluated were included. Results: Overall, 3347 studies were found, of which 199 had their full texts evaluated. A total of 25 records were identified. The prevalence of sarcopenia, as defined by EWGSOP2 criteria, was 23.27% (95%CI 15.4, 33.6). Further, there were differences in sarcopenia prevalence according to the definition used in the studies (p-value = 0.0002). The odds ratio of sarcopenia in people with HF was 2.3 (95%CI 1.1, 4.8). Two studies specifically evaluated sarcopenia in HF-C, reporting a prevalence of 24.2% (95%CI 12.6, 41.5). The odds ratio for sarcopenia in HF-C was 1.93 (95% CI 0.40, 9.30) compared to HF-NC. Conclusions: Patients with HF have an increased risk of developing sarcopenia. However, the prevalence of sarcopenia varies according to the definition used. Furthermore, our findings highlight the hypothesis that the risk of sarcopenia in HF-C might be higher than HF-NC. Author summary: A systematic review of randomized controlled trials, cohort studies, cross-sectional studies, and case-control studies was carried out to estimate the prevalence of sarcopenia in people with heart failure (HF) and assess whether there is a difference in sarcopenia prevalence based on the underlying cause of HF, specifically comparing HF due to Chagas (HF-C) disease with HF from other causes (HF-NC). Overall, 3347 studies were found, of which 199 had their full texts evaluated. A total of 25 records were identified. There were differences in sarcopenia prevalence according to the definition used in the studies (p-value = 0.0002). The odds ratio of sarcopenia in people with HF was 2.3 (95%CI 1.1, 4.8). Two studies specifically evaluated sarcopenia in HF-C, reporting a prevalence of 24.2% (95%CI 12.6, 41.5). The odds ratio for sarcopenia in HF-C was 1.93 (95% CI 0.40, 9.30) compared to HF-NC. Our findings suggest the hypothesis that the risk of sarcopenia in HF-C might be higher than HF-NC.

Date: 2025
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
https://journals.plos.org/plosntds/article?id=10.1371/journal.pntd.0013699 (text/html)
https://journals.plos.org/plosntds/article/file?id ... 13699&type=printable (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:plo:pntd00:0013699

DOI: 10.1371/journal.pntd.0013699

Access Statistics for this article

More articles in PLOS Neglected Tropical Diseases from Public Library of Science
Bibliographic data for series maintained by plosntds ().